Study of Aripiprazole in Patients With Acute Bipolar Mania
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to confirm the safety and effectiveness of aripiprazole
therapy over 12 weeks in subjects with bipolar disorder experiencing symptoms of mania.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.